Back to top

medical: Archive

Zacks Equity Research

Why Should You Retain Anthem (ANTM) Stock in Your Portfolio?

Riding high on a growing top line and higher membership, Anthem (ANTM) holds enough potential to reap benefits for investors.

SEM WCG ANTM GEN

Zacks Equity Research

CVS Health Rides on Aetna Prospects, Strong Selling Season

CVS Health's (CVS) 2020 PBM selling season is approaching closure and the 2021 selling season is ongoing.

RMD HAE CVS EYE

Zacks Equity Research

Implied Volatility Surging for Mallinckrodt (MNK) Stock Options

Investors need to pay close attention to Mallinckrodt (MNK) stock based on the movements in the options market lately.

MNK

Zacks Equity Research

NextGen Healthcare Boosts Patient Care With CHC Strategies

NextGen Healthcare (NXGN) is likely to boost presence in health management with CHC Strategies delivering quality medical care through the company's Population Health platform.

EW CNMD WST NXGN

Zacks Equity Research

Intra-Cellular Therapies (ITCI) in Focus: Stock Moves 6.1% Higher

Intra-Cellular Therapies (ITCI) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

ITCI ANIK

Nikita Kataruka

4 Small Cap Stocks to Get Rid of Before Entering 2020

While domestic economic growth has been benefiting small-cap stocks until now, you should consider selling some of the stocks before entering 2020 because of poor earnings growth projections.

BPFH RRGB AAWW CELC

Zacks Equity Research

LHC Group Set to Gain From Expansion of LifePoint Health JV

LHC Group (LHCG) expects approximately $5.4 million in annualized revenues from this transaction.

LHCG WST CNMD HQY

Zacks Equity Research

Trevi Therapeutics Sees Hammer Chart Pattern: Time to Buy?

Trevi Therapeutics has been struggling lately, but the selling pressure may be coming to an end soon.

TRVI

Zacks Equity Research

Pluristem Therapeutics Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor Pluristem Therapeutics.

PSTI

Sapna Bagaria

UnitedHealth (UNH) to Buy Diplomat, Expand Pharmacy Services

UnitedHealth (UNH) inks an agreement to acquire Diplomat to expand its in-house pharmacy benefit management business.

CI UNH HUM CVS

Zacks Equity Research

Omnicell-Huron Sign a Pact for Outcome-Based Expert Services

Omnicell (OMCL) partners Huron to provide customers with committed expertise.

OMCL RMD HAE EYE

Zacks Equity Research

The Zacks Analyst Blog Highlights: Cross Country Healthcare, Genesis Healthcare, Chuy's, Consulting and Huron Consulting

The Zacks Analyst Blog Highlights: Cross Country Healthcare, Genesis Healthcare, Chuy's, Consulting and Huron Consulting

GEN CHUY FCN HURN CCRN

Zacks Equity Research

Limit Your Exposure to Trade War With These 3 Defensive Funds

Defensive funds could be apt investments as China takes measures for protection against trade war escalation and investors fear a retaliatory action from the United States.

PRHSX FDFAX VGHCX

Zacks Equity Research

Zacks.com featured highlights include: Quanta Services, Alexion Pharmaceuticals, Jazz Pharmaceuticals and Changyou.com

Zacks.com featured highlights include: Quanta Services, Alexion Pharmaceuticals, Jazz Pharmaceuticals and Changyou.com

CYOU PWR ALXN JAZZ

Zacks Equity Research

Company News for Dec 10, 2019

Companies in the news are: ARQL, THOR, CGC, FATE

THOR FATE ARQL CGC

Zacks Equity Research

Worried About Market Downturn? Buy These Low Leverage Stocks

Debt is a much cheaper form of financing than equity. Yet the fact that debt carries the burden of interest payments makes it dearer.

OMCL WCG LULU CNXN CECO

Zacks Equity Research

Options Traders Expect Huge Moves in Aurora (ACB) Stock

Investors need to pay close attention to Aurora (ACB) stock based on the movements in the options market lately.

ACB

Zacks Equity Research

Turning Point (TPTX) Catches Eye: Stock Jumps 6.1%

Turning Point (TPTX) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

IRWD TPTX

Zacks Equity Research

Bruker Launches Luxendo TruLive3D Imager in Mass Spectrometry

Bruker's (BRKR) Luxendo TruLive3D Imager revolutionizes cell culture live imaging in natural environment.

BRKR RMD HAE EYE

Sanghamitra Saha

Deal or No Deal: Healthcare ETFs to Make a Sweep in 2020

While all eyes are on the fate of the phase one trade deal between the United States and China, Healthcare sector can forget tension and soar higher in 2020 even if there is no deal.

BBH VHT XBI XLV IYH

Zacks Equity Research

Globus Medical Hits 52-Week High: What's Driving the Stock?

Globus Medical (GMED) is optimistic about sustaining its growth momentum on recent positive developments.

GMED RMD HAE EYE

Zacks Equity Research

Here's Why You Should Retain NextGen Healthcare for Now

NextGen Healthcare (NXGN) is gaining traction from the U.S. RCM market and the growing EHR market. However, margin pressure remains a concern.

EW WST CNMD NXGN

Zacks Equity Research

Omnicell (OMCL) Partners With Kit Check to Offer Bluesight

This partnership will offer Omnicell (OMCL) the state-of-the art technology and medication intelligence needed to ensure accurate delivery of drugs to the right patients.

OMCL NUVA RMD HAE

Zacks Equity Research

Moving Average Crossover Alert: Heron Therapeutics

Heron Therapeutics is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

HRTX

Zacks Equity Research

Moving Average Crossover Alert: Incyte

Incyte is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

INCY